medigraphic.com
ENGLISH

Salud Pública de México

Instituto Nacional de Salud Pública
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2016, Número 2

<< Anterior Siguiente >>

salud publica mex 2016; 58 (2)


Cancer burden in Mexico: urgent challenges to be met

Lazcano-Ponce E, Mohar-Betancourt A, Meneses-García A, Hernández-Ávila M
Texto completo Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 14
Paginas: 101-103
Archivo PDF: 170.41 Kb.


PALABRAS CLAVE

Sin palabras Clave

FRAGMENTO

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. The Gambia Hepatitis Intervention Study. The Gambia Hepatitis Study Group. Cancer Res 1987;47(21):5782-5787.

  2. Wipfli H, Stillman F, Tamplin S, da Costa e Silva VL, Yach D, Samet J. Achieving the Framework Convention on Tobacco Control’s potential by investing in national capacity. Tob Control 2004;13(4):433-437.

  3. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004;328(7455):1519.

  4. Krugman S. The prevention of viral hepatitis. Ann Clin Res 1976;8(3): 216-220.

  5. Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, et al. Broad Spectrum HPV Vaccine Study, A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015;372(8):711-723.

  6. Michalas SP. The Pap test: George N. Papanicolaou (1883-1962). A screening test for the prevention of cancer of uterine cervix. Eur J Obstet Gynecol Reprod Biol 2000;90(2):135-138.

  7. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community- based randomised controlled trial. Lancet 2011;378(9806):1868-1873.

  8. Monticciolo D, Morris E. Unreliable Conclusions of Breast Cancer Screening, Incidence, and Mortality. JAMA Intern Med 2016;176(1):140-141.

  9. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65(2):87-108.

  10. Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends-An Update. Cancer Epidemiol Biomarkers Prev 2016;25(1):16-27.

  11. Vogelzang NJ, Benowitz SI, Adams S, Aghajanian C, Chang SM, Dreyer ZE, et al. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. J Clin Oncol 2012;30(1):88-109.

  12. Schottenfeld D, Beebe-Dimmer J. The cancer burden attributable to biologic agents. Ann Epidemiol 2015;25(3):183-187.

  13. Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PE, et al. Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol 2015;16(14):1405-1438.

  14. Parkin DM. The role of cancer registries in cancer control. Int J Clin Oncol 2008;13(2):102-111.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

salud publica mex. 2016;58

ARTíCULOS SIMILARES

CARGANDO ...